人参
医学
心肌保护
心功能曲线
心力衰竭
药理学
氧化应激
活性氧
心肌肥大
平衡
线粒体
肌肉肥大
心肌细胞
内科学
心肌梗塞
内分泌学
功能(生物学)
心肌
心室重构
超氧化物歧化酶
病态的
作者
Hideaki Tagashira,Fumiha Abe,Midori Yoshizaki,Tomohiro Numata
出处
期刊:Cureus
[Cureus, Inc.]
日期:2025-12-23
卷期号:17 (12): e99981-e99981
摘要
BACKGROUND: (PG), a principal herb used in Kampo medicine, has been reported to exert cardioprotective effects; however, its intracellular actions under endothelin-1 (ET-1)- and β-adrenergic stress remain incompletely defined. PURPOSE: -reactive oxygen species (ROS) homeostasis in complementary cellular and in vivo stress models. METHODS: Neonatal rat ventricular myocytes (NRVMs) were exposed to ET-1 to induce hypertrophy and mitochondrial fragmentation. Mitochondrial morphology, intracellular Ca²⁺, ROS, and adenosine triphosphate (ATP) levels were quantified by fluorescence imaging and biochemical assays. In mice, isoproterenol (ISO) was administered for 14 days to induce cardiac stress; PG was given orally. Cardiac structure and function were evaluated by histology and echocardiography. Expression of mitochondrial fusion/fission markers was analyzed. All experiments used predefined exclusion criteria and blinded analyses. RESULTS: and ROS in NRVMs. In ISO-treated mice, oral PG (50 mg/kg/day for 14 days) improved systolic function, limited hypertrophic remodeling, and reduced interstitial fibrosis. CONCLUSION: PG exhibits pharmacological cardioprotection associated with modulation of mitochondrial dynamics and attenuation of cellular stress responses. These findings support further investigation of PG as a mitochondria-engaging natural product with the potential to mitigate pathological cardiac remodeling and heart failure progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI